Stock listing

Eupraxia Pharmaceuticals, Inc. (A3EGRS) Stock Price, News, Filings & Events

Selected listing: A3EGRS · LSX · EUR · DE

This page tracks Eupraxia Pharmaceuticals, Inc.'s A3EGRS:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3EGRS:LSX. A3EGRS:LSX is the selected stock listing for investors researching Eupraxia Pharmaceuticals, Inc.; the company-level investor brief is shared across the issuer while this page keeps ticker, exchange, currency, and canonical URL signals specific to A3EGRS:LSX. Eupraxia Pharmaceuticals, Inc. is a public company listed on the Canadian market under the listed on 6ix. 7 million. Eupraxia focuses on developing innovative therapies to address unmet medical needs.

websiteA3EGRS:LSXEURDESEO content: aiUpdated June 24, 2026/stock/lsx-a3egrs/eupraxia-pharmaceuticals-inc/l-id5aqknfqy
Eupraxia Pharmaceuticals, Inc. logo
Ticker
A3EGRS:LSX
Asset type
Stock
Market cap
$423.7M
Sector
Health Technology
Industry
Biotechnology
Exchange
LSX
Currency
EUR

Eupraxia Pharmaceuticals, Inc. A3EGRS:LSX stock context

This page tracks Eupraxia Pharmaceuticals, Inc.'s A3EGRS:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3EGRS:LSX. A3EGRS:LSX is the selected stock listing for investors researching Eupraxia Pharmaceuticals, Inc.; the company-level investor brief is shared across the issuer while this page keeps ticker, exchange, currency, and canonical URL signals specific to A3EGRS:LSX. Eupraxia Pharmaceuticals, Inc. is a public company listed on the Canadian market under the listed on 6ix. 7 million. Eupraxia focuses on developing innovative therapies to address unmet medical needs.

Research Eupraxia Pharmaceuticals, Inc.

Alternate listings